PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

VA · US

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$3,052,000

Connections

7

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

PHAPharmacy
$5.1M
MMMMedicare/Medicaid
$5.1M
TAXTaxation/Internal Revenue Code
$5.1M
ALCAlcohol/Drug Abuse
$5.1M
LBRLabor/Employment
$5.1M
DEFDefense
$5.1M
BUDBudget/Appropriations
$5.1M
TECScience/Technology
$3.3M
SMBSmall Business
$2.5M
TRDTrade
$2.3M

Lobbying Firms Retained

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION$5.1M
BGR GOVERNMENT AFFAIRS$20K

Bills Referenced in Lobbying Filings

H.R. 2670PBM

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
commented_onCenters for Medicare & Medicaid ServicesPublic comment on CMS-2023-0092: Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates under the Medicaid Drug Rebate ProgramSource
Lobbied forPharmacy Benefit Manager Reform ActLDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $370,000Source
Lobbied forNational Defense Authorization Act FY2024 (H.R.2670)LDA filing: lobbied on NDAA FY2024, period 2nd Quarter (Apr 1 - June 30), reported amount $380,000Source
Lobbied forNational Defense Authorization Act FY2024 (H.R.2670)LDA filing: lobbied on NDAA FY2024, period 2nd Quarter (Apr 1 - June 30), reported amount $380,000Source
Lobbied forAction to Delay Effective Date Consistent With Congressionally Enacted MoratoriumLobbied on pbm — matched LDA filing topic to Federal Register rule.Source
Lobbied forImproving Transparency Into Pharmacy Benefit Manager Fee Disclosure; Extension of Comment PeriodLobbied on pbm — matched LDA filing topic to Federal Register rule.Source
Employed byBGR GOVERNMENT AFFAIRSHired BGR GOVERNMENT AFFAIRS to lobby (2nd Quarter (Apr 1 - June 30) 2026)Source